Self- vs provider-referral differences for coronary artery calcium testing

Self- vs provider-referral differences for coronary artery calcium testing

Study objectives: The objectives of this study were to identify independent predictors for moderate/accentuated coronary artery calcium (CAC) score and compare patients who self-referred for CAC Computed Tomography (CT) testing to those who were provider-referred. Design: Patients underwent CAC betw...

Full description

Bibliographic Details
Main Authors:	Rebekah Lantz, Steve Young, Janet Lubov, Anas Ahmed, Ronald Markert, Srikanth Sadhu
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	American Heart Journal Plus
Subjects:	Coronary Calcification Statin Hyperlipidemia CAC ASCVD
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666602222000052

Similar Items

Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA)
by: Jian H. Chu, et al.
Published: (2022-09-01)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

High- vs. Low-Intensity Statin Therapy and Changes in Coronary Artery Calcification Density after One Year
by: Lukas Hermann Vogel, et al.
Published: (2023-01-01)

Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort
by: Bassam Atallah, et al.
Published: (2020-02-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system
by: Neha M. Mantri, et al.
Published: (2022-12-01)

LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01)

Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study
by: Teeraboon Lertwanichwattana, et al.
Published: (2021-03-01)

Utility of coronary artery calcium in refining 10-year ASCVD risk prediction using a Thai CV risk score
by: Noppanat Tiansuwan, et al.
Published: (2023-11-01)

Coronary calcification with no flow limiting lesions: A potential cause for ischaemic dysfunction in syndrome X patients
by: Elisabetta Palmerini, et al.
Published: (2015-12-01)

Factors affecting statin uptake among people living with HIV: primary care provider perspectives
by: Allison J. Ober, et al.
Published: (2021-10-01)

Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
by: Kjell-Erik Arnesen, et al.
Published: (2021-03-01)

Coronary artery calcification as a predictor of adverse outcomes in patients hospitalized with COVID-19
by: Srisha Kotlo, et al.
Published: (2023-04-01)

Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01)

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
by: Chad Gier, et al.
Published: (2024-01-01)

Coronary artery calcium scoring as a tool for risk stratification in patients with an elevated lipoprotein(a) level
by: Robert Naami, et al.
Published: (2022-12-01)

Statin efficacy in the treatment of hepatitis C genotype I
by: Ahmad Shavakhi, et al.
Published: (2014-01-01)

Managing dyslipidemia in solid organ transplant patients
by: Ashwani Mehta
Published: (2024-03-01)

Coronary artery calcifications on breast cancer radiotherapy planning CT scans and cardiovascular risk: What do patients want to know?
by: Roxanne Gal, et al.
Published: (2021-12-01)

Role of imaging in primary prevention: calcium score is a robust and cost-efficient risk modifier
by: H. Yakup Yakupoglu, et al.
Published: (2019-12-01)

Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future
by: Michael D. Shapiro, et al.
Published: (2020-03-01)

The effects of hyperlipidemia on rotator cuff diseases: a systematic review
by: Yang Yang, et al.
Published: (2018-08-01)

The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer
by: Raza M. Alvi, et al.
Published: (2022-07-01)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
by: Lei Bi, et al.
Published: (2022-03-01)

Clinical efficacy and safety outcomes of bempedoic acid: An updated systematic review and meta-analysis after CLEAR Outcomes trial
by: Amit Bhandari, et al.
Published: (2023-12-01)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020-12-01)

Rapid Regression of Carotid Artery Stenosis Shortly after Intensive Medical Therapy
by: Suh Yeon Park, et al.
Published: (2022-02-01)

The Comparison of Penile Doppler Ultrasonography Findings with Serum Lipid Parameters in Hyperlipidemic Patients with Erectile Dysfunction
by: Mustafa Tasdemir, et al.
Published: (2021-05-01)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
by: Umair Iqbal, et al.
Published: (2018-09-01)

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality
by: Leili Pourafkari, et al.
Published: (2016-03-01)

High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study
by: Lin TK, et al.
Published: (2018-01-01)

Omega-3 (<i>n</i>-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
by: Ivana Djuricic, et al.
Published: (2024-03-01)

Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management
by: Mohd Waiz, et al.
Published: (2022-01-01)

Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities
by: Qiaowei Li, et al.
Published: (2020-03-01)

Association between the homeostasis model assessment of insulin resistance and coronary artery calcification: a meta-analysis of observational studies
by: Longti Li, et al.
Published: (2023-11-01)

Value of Coronary Artery Calcium Scoring in Iranian Patients Suspected to Coronary Artery Disease
by: Amir Farhang Zand Parsa, et al.
Published: (2015-06-01)

Effects of Hyperlipidemia on Osseointegration of Dental Implants and Its Strategies
by: Haiyang Sun, et al.
Published: (2023-03-01)

The Underutilization, Adverse Reactions and Efficacy of Statins after Liver Transplant: A Meta-Analysis and Systematic Review
by: Yeung Jek Ho, et al.
Published: (2021-07-01)

High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice
by: M. G Bubnova
Published: (2017-12-01)

Effect of statins on hearing function and subjective tinnitus in hyperlipidemic patients
by: Yücel Hilal, et al.
Published: (2019-06-01)